Stock INDOCO INDOCO REMEDIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Indoco Remedies Limited

Equities

INDOCO

INE873D01024

Market Closed - NSE India S.E.
Other stock markets
 05:13:52 31/05/2024 pm IST 		5-day change 1st Jan Change
300.4 INR -3.25% Intraday chart for Indoco Remedies Limited -3.73% -23.98%
22/05 Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules MT
21/05 Indoco Remedies Ltd. Receives Final ANDA Approval from USFDA for Pregabalin Capsules CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules
MT
Indoco Remedies Ltd. Receives Final ANDA Approval from USFDA for Pregabalin Capsules
CI
Indoco Remedies Limited Receives Show Cause Notice from Office of the Joint Commissioner of State Tax Patna Special Circle, Patna Bihar
CI
Indoco Remedies Gets Zero Observations from US FDA for Navi Mumbai, India Plant, IAS Division
MT
Transcript : Indoco Remedies Limited, Q4 2024 Earnings Call, May 16, 2024
Indoco Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Indoco Remedies Limited Receives Show Cause Notice Received from the Goods and Service Tax Authority
CI
Indoco Remedies Limited Announces Cessation of Divakar M. Gavaskar and Rajiv P. Kakodkar as Independent Directors, Effective Mach 31, 2024
CI
Indoco Remedies Arm Begins Commercial Production from New Manufacturing Unit
MT
Indoco Remedies to Buy Land in Mumbai for Expansion
MT
Indoco Remedies Arm Begins Commercial Production at New Oral Care Unit
MT
Transcript : Indoco Remedies Limited, Q3 2024 Earnings Call, Jan 23, 2024
Indoco Remedies' Consolidated Profit Slumps in Fiscal Q3; Shares Drop 6%
MT
Indoco Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Indoco Remedies Gets Establishment Inspection Report from US FDA after Goa Unit Inspection
MT
Indoco Remedies Gets Tentative US FDA Nod for Generic Diabetes Drug
MT
Indoco Remedies Receives Tentative ANDA Approval from USFDA for Canagliflozin Tablets
CI
Indoco Remedies' Solid Oral Formulation Plant in Goa, India, Gets Four Observations from US FDA
MT
Transcript : Indoco Remedies Limited, Q2 2024 Earnings Call, Oct 19, 2023
Indoco Remedies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INDOCO Stock
  4. News Indoco Remedies Limited